AAAAAA

   
Results: 1-16 |
Results: 16
A single nucleotide polymorphism in the 5 ' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers
Authors: Wang, WW Spurdle, AB Kolachana, P Bove, B Modan, B Ebbers, SM Suthers, G Tucker, MA Kaufman, DJ Doody, MM Tarone, RE Daly, M Levavi, H Pierce, H Chetrit, A Yechezkel, GH Chenevix-Trench, G Offit, K Godwin, AK Struewing, JP
Citation: Ww. Wang et al., A single nucleotide polymorphism in the 5 ' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers, CANC EPID B, 10(9), 2001, pp. 955-960
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives
Authors: Runnebaum, IB Wang-Gohrke, S Vesprini, D Kreienberg, R Lynch, H Moslehi, R Ghadirian, P Weber, B Godwin, AK Risch, H Garber, J Lerman, C Olopade, OI Foulkes, WD Karlan, B Warner, E Rosen, B Rebbeck, T Tonin, P Dube, MP Kieback, DG Narod, SA
Citation: Ib. Runnebaum et al., Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives, PHARMACOGEN, 11(7), 2001, pp. 635-638
Identification in the human candidate tumor suppressor gene HIC-1 of a newmajor alternative TATA-less promoter positively regulated by p53
Authors: Guerardel, C Deltour, S Pinte, S Monte, D Begue, A Godwin, AK Leprince, D
Citation: C. Guerardel et al., Identification in the human candidate tumor suppressor gene HIC-1 of a newmajor alternative TATA-less promoter positively regulated by p53, J BIOL CHEM, 276(5), 2001, pp. 3078-3089
Destabilization of CHK2 by a missense mutation associated with Li-Fraumenisyndrome
Authors: Lee, SB Kim, SH Bell, DW Wahrer, DCR Schiripo, TA Jorczak, MM Sgroi, DC Garber, JE Li, FP Nichols, KE Varley, JM Godwin, AK Shannon, KM Harlow, E Haber, DA
Citation: Sb. Lee et al., Destabilization of CHK2 by a missense mutation associated with Li-Fraumenisyndrome, CANCER RES, 61(22), 2001, pp. 8062-8067
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history
Authors: Rebbeck, TR Wang, YT Kantoff, PW Krithivas, K Neuhausen, SL Godwin, AK Daly, MB Narod, SA Brunet, JS Vesprini, D Garber, JE Lynch, HT Weber, BL Brown, M
Citation: Tr. Rebbeck et al., Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history, CANCER RES, 61(14), 2001, pp. 5420-5424
Identification and structural analysis of human RBM8A and RBM8B: Two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor
Authors: Salicioni, AM Xi, MR Vanderveer, LA Balsara, B Testa, JR Dunbrack, RL Godwin, AK
Citation: Am. Salicioni et al., Identification and structural analysis of human RBM8A and RBM8B: Two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor, GENOMICS, 69(1), 2000, pp. 54-62
CEL I enzymatic mutation detection assay
Authors: Kulinski, J Besack, D Oleykowski, CA Godwin, AK Yeung, AT
Citation: J. Kulinski et al., CEL I enzymatic mutation detection assay, BIOTECHNIQU, 29(1), 2000, pp. 44
ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle
Authors: Grobelny, JV Godwin, AK Broccoli, D
Citation: Jv. Grobelny et al., ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle, J CELL SCI, 113(24), 2000, pp. 4577-4585
Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary
Authors: Bruening, W Giasson, BI Klein-Szanto, AJP Lee, VMY Trojanowski, JQ Godwin, AK
Citation: W. Bruening et al., Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary, CANCER, 88(9), 2000, pp. 2154-2163
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers
Authors: Rebbeck, TR Levin, AM Eisen, A Snyder, C Watson, P Cannon-Albright, L Isaacs, C Olopade, O Garber, JE Godwin, AK Daly, MB Narod, SA Neuhausen, SL Lynch, HT Weber, BL
Citation: Tr. Rebbeck et al., Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers, J NAT CANC, 91(17), 1999, pp. 1475-1479
Genome scanning detects amplification of the cathepsin B gene (CtsB) in transformed rat ovarian surface epithelial cells
Authors: Abdollahi, A Getts, LA Sonoda, G Miller, PD Taguchi, T Godwin, AK Testa, JR Hamilton, TC
Citation: A. Abdollahi et al., Genome scanning detects amplification of the cathepsin B gene (CtsB) in transformed rat ovarian surface epithelial cells, J SOC GYN I, 6(1), 1999, pp. 32-40
The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability
Authors: Riccio, A Aaltonen, LA Godwin, AK Loukola, A Percesepe, A Salovaara, R Masciullo, V Genuardi, M Paravatou-Petsotas, M Bassi, DE Ruggeri, BA Klein-Szanto, AJP Testa, JR Neri, G Bellacosa, A
Citation: A. Riccio et al., The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability, NAT GENET, 23(3), 1999, pp. 266-268
Genomic differentiation of 18S ribosomal DNA and beta-satellite DNA in thehominoid and its evolutionary aspects
Authors: Hirai, H Taguchi, T Godwin, AK
Citation: H. Hirai et al., Genomic differentiation of 18S ribosomal DNA and beta-satellite DNA in thehominoid and its evolutionary aspects, CHROMOS RES, 7(7), 1999, pp. 531-540
Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer
Authors: Kruk, PA Godwin, AK Hamilton, TC Auersperg, N
Citation: Pa. Kruk et al., Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer, GYNECOL ONC, 73(2), 1999, pp. 229-236
Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells
Authors: Bruening, W Prowse, AH Schultz, DC Holgado-Madruga, M Wong, A Godwin, AK
Citation: W. Bruening et al., Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells, CANCER RES, 59(19), 1999, pp. 4973-4983
Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat
Authors: Rebbeck, TR Kantoff, PN Krithivas, K Neuhausen, S Blackwood, MA Godwin, AK Daly, MB Narod, SA Garber, JE Lynch, HT Weber, BL Brown, M
Citation: Tr. Rebbeck et al., Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat, AM J HU GEN, 64(5), 1999, pp. 1371-1377
Risultati: 1-16 |